drugset / Trial / NCT00857909

The Effect of Amiloride and Spironolactone in Healthy Persons

NCT00857909

Phase 1 Completed 30 enrolled Regional Hospital Holstebro
RandomizedCrossoverDouble-blindTreatment

Summary

This study will investigate whether retaining potassium in the body will lead to changes in blood pressure and changes in blood and urine samples.

Timeline

Start
2009-01
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiloride Small molecule 5 mg
Comparator Spironolactone Small molecule 5 mg
Comparator Spironolactone Small molecule 25 mg

Indications